GILD

Gilead Sciences Inc

Jun 18 • 04:00PM ET

123.76

-1.69 -1.35 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: AMGN REGN VRTX BIIB ABBV BMY LLY MRK ALNY ARGX

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	16.84	EPS (ttm)	7.35	Insider Own	0.14%	Shs Outstand	1.24B	Perf Week	-1.68%
Market Cap	153.66B	Forward P/E	12.74	EPS next Y	9.72	Insider Trans	-18.22%	Shs Float	1.24B	Perf Month	-5.16%
Enterprise Value	165.93B	PEG	1.38	EPS next Q	-7.32	Inst Own	88.79%	Short Float	2.07%	Perf Quarter	-12.30%
Income	9.22B	P/S	5.16	EPS this Y	-109.81%	Inst Trans	-1.49%	Short Ratio	3.79	Perf Half Y	4.19%
Sales	29.79B	P/B	6.54	EPS next Y	1315.48%	ROA	16.35%	Short Interest	25.73M	Perf YTD	0.83%
Book/sh	18.93	P/C	15.65	EPS next 5Y	9.20%	ROE	43.19%	52W High	157.29 -21.32%	Perf Year	14.59%
Cash/sh	7.91	P/FCF	15.02	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	104.46 18.48%	Perf 3Y	56.94%
Dividend Est.	3.24 (2.62%)	EV/EBITDA	11.24	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.75% 2.73%	Perf 5Y	85.80%
Dividend TTM	3.22 (2.60%)	EV/Sales	5.57	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.62	Perf 10Y	49.74%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	39.38	Recom	1.53
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-3.92%	Beta	0.35	Target Price	160.78
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-6.09%	Rel Volume	2.08	Prev Close	125.45
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	-4.36%	Avg Volume	6.78M	Price	123.76
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	14,075,851	Change	-1.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)